Skip to main content
Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
1.540
0.00 (0.00%)
At close: Jan 21, 2025, 4:00 PM
1.520
-0.020 (-1.30%)
After-hours: Jan 21, 2025, 7:12 PM EST

SONN Revenue

In the fiscal year ending September 30, 2024, Sonnet BioTherapeutics Holdings had annual revenue of $18.63K, down -87.40%.

Revenue (ttm)
$18.63K
Revenue Growth
-87.40%
P/S Ratio
54.18
Revenue / Employee
$1,433
Employees
13
Market Cap
4.63M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202418.63K-129.18K-87.40%
Sep 30, 2023147.81K-202.14K-57.76%
Sep 30, 2022349.94K-133.68K-27.64%
Sep 30, 2021483.63K--
Sep 30, 2020---
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 87.70B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher Scientific 42.37B
Abbott Laboratories 41.22B
Revenue Rankings

SONN News

More News